A Study of Modified mRNA Vaccines in Healthy Adults

NCT05397223 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

308

Enrollment

INDUSTRY

Sponsor class

Conditions

SARS-CoV-2
Seasonal Influenza
Respiratory Syncytial Virus
Cytomegalovirus

Interventions

BIOLOGICAL: mRNA-1273
BIOLOGICAL: mRNA-1010
BIOLOGICAL: mRNA-1345
BIOLOGICAL: FLUAD®
BIOLOGICAL: mRNA-1647

Sponsor

ModernaTX, Inc.